Sentences with phrase «potential diabetes treatment»

Not exact matches

Chia is being studied as a potential natural treatment for type - 2 diabetes because of its ability to slow down digestion.

Stem cell research and diabetes Stem cell research is a relatively new area of investigation, believed by many in the scientific and medical communities to have important new potential for the treatment of many diseases and conditions particularly those like diabetes, which are characterised by severe damage to certain cells and tissues..

«This is a very exciting finding, obtained by studying patients» cells, that has the potential to result in a new treatment for this chronic complication of longstanding Type 1 diabetes,» Dr. Folli said.

«This work validates a new potential target for the treatment of diabetes,» Liu said.

With the discovery of a compound that can slow the degradation of insulin in animals, scientists at Harvard have opened the door to a potential new treatment for diabetes.

«Potential cost savings for early detection and treatment of type 2 diabetes.»

«Fat turns from diabetes foe to potential treatment.»

This study contributes to our previous research by showing that early detection and treatment among individuals at high risk of type 2 diabetes has the potential to reduce costs.»

However, it is commonly associated with diabetes, which has prompted researchers to test diabetes medications, such as metformin, rosiglitazone and liraglutide, as potential treatments.

Hypoglycemia is a serious potential complication of diabetes treatment.

While the study did not support earlier findings that sitagliptin was an effective treatment for NAFLD, Loomba said it provided new evidence that clinical trials with patients at higher risk of diabetes do not necessarily need a liver biopsy to be efficiently screened for potential therapeutic agents.

But the new study firmly establishes that some of these cells endure for many decades in some Medalists — offering clues to potential treatments for preserving and even restoring the crucial cell population, says George L. King, M.D., senior author on the paper, Joslin's chief scientific officer and head of the Dianne Nunnally Hoppes Laboratory for Diabetes Complications.

The Company's potential breakthrough treatment for high - risk type 1 diabetes, called PEC - DirectTM is expected to begin clinical trials early next year.

These lines would allow scientists to better study conditions ranging from diabetes to Parkinson's disease, and they would provide the basis for potential patient - specific stem cell treatments.

Michigan Medicine and MedImmune, the global biologics research and development arm of AstraZeneca (NYSE: AZN), have entered into a three - year research alliance to identify potential new therapies for the prevention and treatment of diabetes, obesity and related metabolic disorders.

The VC - 01 product candidate is being developed as a potential long - term diabetes treatment with the goals of no immune suppression required, and a reduced risk of hypoglycemia and diabetes - related complications.

The researchers are optimistic about the chances of this potential treatment when it comes to encouraging insulin production among people who suffer from type 2 diabetes.

The VC - 01 product candidate is being developed as a potential long - term diabetes treatment with the goal of reducing the risk of hypoglycemia and diabetes - related complications without requiring long - term immune suppression.

The CIRM board also announced the approval of US $ 58.8 million in funding for five new clinical trials which will study potential treatments for a variety of diseases and conditions, namely malignant glioma, acute myeloid leukemic, neutropenia, high - risk type 1 diabetes and kidney disease.

Studies using a mouse model of type 1 diabetes highlight a potential role for human adipose stem cells in treatment regimens and, further, they reveal a secreted factor which has important therapeutic relevance

Again, these experiments clearly highlight that PTP1B could be a very important player in the development of insulin resistance, and this has actually led to a number of pharmaceutical companies developing drugs, trying to develop inhibitors of PTP1B as potential drugs for treatment of obesity and type II diabetes.

This study provides further evidence that BAT is a very important metabolic organ and a potential treatment for obesity - related diseases such as diabetes, metabolic syndrome and insulin resistance,» says lead author Kristin I. Stanford, PhD, a postdoctoral fellow in the Section on Integrative Physiology and Metabolism.

VC - 01 is being developed as a potential long - term diabetes treatment without immune suppression, and without risk of hypoglycemia or other diabetes - related complications.

The Company's pluripotent stem cell - derived islet cell replacement therapy, the PEC - Direct ™ product candidate, has the potential to be a breakthrough treatment for high - risk type 1 diabetes.

1) The discovery that pancreatic beta cells, which produce insulin, have the ability to be regenerated from stem cells or ductal cells in the pancreas, indicating that one potential treatment for type 1 diabetes is to stimulate beta cells to regrow even after many years of living with diabetes

Numerous international publications testify to the research group's commitment to identifying metabolic and molecular pathways as potential targets for innovative therapies that combine nutraceutical intervention and physical exercise, for the prevention and treatment of insulin resistance, of diabetes and associated complications.

Parvus Therapeutics is focused on the development and commercialization of the nanotechnology - based therapeutic platform for the potential treatment of type 1 diabetes.

A potential explanation for the secular trend may be that while improved treatment for cardiovascular risk factors or complicating diseases has reduced mortality in all weight classes, the effects may have been greater at higher BMI levels than at lower BMI levels.12 Because obesity is a causal risk factor for hypertension, diabetes, cardiovascular disease, and dyslipidemia,15,19 - 22 obese individuals may have had a higher selective decrease in mortality.18 Indirect evidence of this effect is seen in the findings as the deaths occur at similar time periods in the 3 cohorts, but cohorts recruited at later periods have an increase in the BMI associated with the lowest mortality, possibly suggesting a period effect related to changes in clinical practice, such as improved treatments, or general public health status, such as decreased smoking or increased physical activity.

«Further, this is a potential treatment for Parkinson's disease, Huntington's disease, multiple sclerosis and amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), drug resistant epilepsy, brittle type I diabetes, and diabetes type II, where there is insulin resistance.

The researchers attributed these positive results to the antioxidant and antihyperglycemic properties of cabbage, which «offer a potential therapeutic source for the treatment of diabetes.»

More studies are needed, but the research so far shows promise with goji berries for potential diabetes and heart disease treatments or prevention.

The ketogenic diet has recently taken off as a potential treatment option for many medical issues, including obesity, diabetes, and neurodegenerative disease.

These treatments have not shown as wide success as the newer medications listed above, plus they have been fraught with serious side effect potential (mammary cancer and / or induction of diabetes mellitus).

An understanding of the genetic basis of variability of these cells and proteins, and of the association of this variability with a variety of diseases that commonly affect cats, including diabetes, has the potential to dramatically improve the diagnosis and treatment of cats with these conditions.

It will also provide relevant findings regarding treatment of GDM and its impact on complications such as diabetes and obesity and may thus help to elucidate potential solutions, thus leading to significant changes in clinical practice and guidelines.

Pubertal status was measured to control for its potential effects on diabetes - related conflict and adherence to treatment.